Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EpcoReal: A Multi-country, Prospective Observational Study of Epcoritamab in NHL Comprising Two Patient Cohorts (3L+ (D)LBCL and 3L+ FL)

NCT06830759 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT06830759
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06830759 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EpcoReal: A Multi-country, Prospective Observational Study of Epcoritamab in NHL Comprising Two Patient Cohorts (3L+ (D)LBCL and 3L+ FL)
Lead sponsor
AbbVie
Phase
Observational
Overall status
Recruiting
Start date
March 28, 2025
Completion date
September 30, 2031
Enrollment
700 (estimated)
Sites
73

Conditions

As the registry lists them; a condition with its own page is linked.

diffuse large b-cell lymphoma, follicular lymphoma